Relmada Therapeutics Stock Performance
as on October 3, 2026 at 2:15 pm IST
Day's High
$3.60$3.733.61%
Upside
52 Week's Low
52 Week's High
$1.80$8.00
49.91%
Downside
122.22%
Upside
Relmada Therapeutics share price movements today
- Previous Close
- $3.66
- Open
- $3.72
- Volume
- 812.5K
- Market Cap
- $390.4M
- Day's Low - High
- $3.60 - $3.73
- 52 Week Low - High
- $1.80 - $8.00
Relmada Therapeutics Historical Returns
- 1 Month Return
- -17.62 %
- 3 Month Return
- -42.68 %
- 1 Year Return
- + 55.17 %
- 3 Year Return
- + 16.13 %
- 5 Year Return
- -86.54 %
Relmada Therapeutics Stock Fundamentals & Key Indicators
Check Relmada Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$390.4M
EPS (TTM)
-0.92
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.04
Industry PE ratio
-6.16
PEG Ratio
-0.04
EBITDA
-61.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-47.52%
Relmada Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Relmada Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $390.4M | -86.54% | -4.04 | 0.00% | 0.00% | |
| StrongBuy | $44.1B | 609.62% | -23.34 | 0.00% | 0.00% | |
| Neutral | $75.4B | -44.29% | -24.08 | -12.57% | 0.00% | |
| StrongBuy | $132.5B | 180.98% | 30.19 | 86.04% | 0.00% | |
| Buy | $78.1B | 28.80% | 17.67 | 84.86% | 0.50% |
Stock Returns calculator for Relmada Therapeutics Stock including INR - Dollar returns
The Relmada Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Relmada Therapeutics investment value today
Current value as on today
₹1,68,430
Returns
₹68,430
(+68.43%)
Returns from Relmada Therapeutics Stock
₹55,172 (+55.17%)
Dollar Impact
₹13,258 (+13.26%)
Analyst Recommendation on Relmada Therapeutics Stock
Based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Relmada Therapeutics. Average target price of $10.75
Relmada Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Relmada Therapeutics.
What analysts predicted
66.51%UPSIDE
Target Price
$10.75
Current Price
$3.6
Analyzed by
2 Analysts
High
$12
Target
$10.75
Low
$12
Relmada Therapeutics target price $10.75, a slight upside of 66.51% compared to current price of $3.6. According to 2 analysts rating.
Indian Investors' Interest in Relmada Therapeutics Stock
Search interest for Relmada Therapeutics Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
Relmada Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Relmada Therapeutics Annual Profit & Loss
All numbers in Millions USD
Relmada Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Relmada Therapeutics Annual Cash Flow
All numbers in Millions USD
Relmada Therapeutics News & Key Events
Today's Timeline - 09 March
Mon, 06:18 PM
-Relmada Therapeutics shares rise after promising Phase 2 trial data for NDV-01 in bladder cancer treatment.
Insights on Relmada Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 511.7%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 84.3% return, outperforming this stock by 68.2%
NEGATIVE IMPACTPrice Dip
In the last 3 months, RLMD stock has moved down by -42.7%
About Relmada Therapeutics
| Organisation | Relmada Therapeutics |
| Headquarters | 2222 Ponce de Leon Blvd., Coral Gables, FL, 33134, US |
| Industry | Biotechnology |
| CEO | Sergio Traversa |
Key Management of Relmada Therapeutics
Name | Title |
|---|---|
Dr. Sergio Traversa M.B.A., Pharm.D. | CEO & Director |
Mr. Maged S. Shenouda M.B.A., R.Ph. | Chief Financial Officer |
Mr. Paul E. Kelly M.B.A. | COO & Director |
Mr. Charles S. Ence CPA, M.B.A. | Chief Accounting & Compliance Officer |
Ms. Gina DiGuglielmo | VP & Head of Clinical Operations |
FAQs
What is Relmada Therapeutics share price today?
Relmada Therapeutics share price today is $3.60 as on at the close of the market. Relmada Therapeutics share today touched a day high of $3.73 and a low of $3.60.
What is the 52 week high and 52 week low for Relmada Therapeutics share?
Relmada Therapeutics share touched a 52 week high of $8.00 on and a 52 week low of $1.80 on . Relmada Therapeutics stock price today i.e. is closed at $3.60,which is 55.00% down from its 52 week high and 99.63% up from its 52 week low.
What is Relmada Therapeutics's market capitalisation today?
Relmada Therapeutics market capitalisation is $0.00T as on .
How to invest in Relmada Therapeutics Stock (RLMD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Relmada Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Relmada Therapeutics Stock (RLMD) from India?
Indian investors can start investing in Relmada Therapeutics (RLMD) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Relmada Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Relmada Therapeutics share’s latest price of $3.60 as on October 3, 2026 at 8:45 am IST, you will get 2.7778 shares of Relmada Therapeutics. Learn more about
fractional shares .
What are the returns that Relmada Therapeutics has given to Indian investors in the last 5 years?
Relmada Therapeutics stock has given -86.54% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?